🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 51 of 200 · A–Z by INN

  1. degarelix

    FIRMAGON 120MG Ferring Pharmaceuticals

    EMA: approved · TGA: approved

    L02BX02

  2. degarelix acetate

    FIRMAGON

    SUBCUTANEOUS FDA: approved

  3. dehydrated alcohol

    ABLYSINOL

    INTRA-ARTERIAL FDA: approved

  4. delafloxacin

    QUOFENIX

    EMA: approved

    J01MA23

  5. delafloxacin meglumine

    BAXDELA

    ORAL FDA: approved

  6. delamanid

    DELTYBA

    EMA: approved · PMDA: approved

    J04AK06

  7. delandistrogene moxeparvovec

    ELEVIDYS

    EMA: refused

    M09AX15

  8. delavirdine mesylate

    RESCRIPTOR

    ORAL FDA: approved

  9. delgocitinib

    ANZUPGO

    TOPICAL FDA: approved · EMA: approved · PMDA: approved

    D11AH11

  10. demecarium bromide

    HUMORSOL

    OPHTHALMIC FDA: approved

  11. demeclocycline hydrochloride

    DECLOMYCIN Amneal Pharma Europe Ltd

    ORAL FDA: approved

  12. dendritic

    NMPA: clinical trials

  13. dengue tetravalent vaccine (live, attenuated)

    QDENGA Takeda

    EMA: approved

    J07BX04

  14. denileukin diftitox

    ONTAK

    FDA: approved

  15. denileukin diftitox-cxdl

    LYMPHIR Citius Pharmaceuticals

    INJECTION FDA: approved

  16. denosumab

    CORORA Amgen

    SUBCUTANEOUS FDA: approved · EMA: approved · TGA: approved · PMDA: approved

    M05BX04

  17. denosumab-adet

    PONLIMSI Teva Pharma GmbH

    SUBCUTANEOUS FDA: approved

  18. denosumab-bbdz

    JUBBONTI

    SUBCUTANEOUS FDA: approved

  19. denosumab-bmwo

    OSENVELT

    INJECTION FDA: approved

  20. denosumab-bnht

    CONEXXENCE

    FDA: approved

  21. denosumab-desu

    OSVYRTI

    SUBCUTANEOUS FDA: approved

  22. denosumab-dssb

    DENOSUMAB-DSSB

    SUBCUTANEOUS FDA: approved

  23. denosumab-kyqq

    AUKELSO

    INJECTION FDA: approved

  24. denosumab-mobz

    BONCRESA Amneal Pharma Europe Ltd

    SUBCUTANEOUS FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources